Skip to main content
OpenTrials
Completed

NCT Number: NCT02126176

Protopic Adherence and Efficacy in Korean Eczema Patient

The purpose of this study is to determine whether the dosage of 0.1% tacrolimus ointment applied on unit area of eczema influence the efficacy of treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Atopic Dermatitis Congenital, Hereditary, and Neonatal Diseases and Abnormalities Dermatitis Dermatitis, Atopic Genetic Diseases, Inborn Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Skin Diseases Skin Diseases, Eczematous Skin Diseases, Genetic Skin and Connective Tissue Diseases

Age range

19 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of dermatology, Pusan National University Hospital

Busan, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • at least 19 years of age with a diagnosis of atopic dermatitis
  • treated with protopic 0.1% ointment

Exclusion criteria

  • treated with other medication or topical agent
  • skin lesion on the scalp or hand and foot
  • pregnant women/lactating women

Treatment and study plan

Primary outcomes

  1. clinical assessments of erythema, scaling, and pruritus

    Time frame: 2 weeks

    EASI score

  2. clinical assessments of erythema, scaling, and pruritus

    Time frame: 2 weeks

    TIS score

  3. clinical assessments of erythema, scaling, and pruritus

    Time frame: 2 weeks

    IGA/PGA score

  4. clinical assessments of erythema, scaling, and pruritus

    Time frame: 2 weeks

    DLQI

  5. clinical assessments of erythema, scaling, and pruritus

    Time frame: 2 weeks

    itching VAS scale

Sponsors and collaborators

Lead sponsor

Pusan National University Hospital

Other

Registry information

Important dates

Study start
2014
Primary completion
2016
Study completion
2016
First posted
Apr 29, 2014
Registry last updated
Mar 30, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.